Literature DB >> 20722762

Persistent viral infection in humans can drive high frequency low-affinity T-cell expansions.

Naeem Khan1, Mark Cobbold, Joanne Cummerson, Paul A H Moss.   

Abstract

CD8 T cells that recognize cytomegalovirus (CMV) -encoded peptides can be readily detected by staining with human leucocyte antigen (HLA) -peptide tetramers. These cells are invariably highly differentiated effector memory cells with high avidity T-cell receptors (TCR). In this report we demonstrate an HLA-A*0201 restricted CMV-specific CD8 T-cell response (designated YVL) that represents several percent of the CD8 T-cell subset, yet fails to bind tetrameric major histocompatibility complex (MHC) ligands. However, these tetramer-negative cells are both phenotypically and functionally similar to other CMV-specific CD8 T cells. YVL peptide-specific CD8 T-cell clones were generated and found to be of high avidity in both cytotoxicity and interferon-γ (IFN-γ) assays, and comparable with other CMV peptide-specific CD8 T-cell clones. However, under conditions of CD8 blockade, the response was almost nullified even at very high ligand concentrations. This was also the case in IFN-γ experiments using peripheral blood mononuclear cells stimulated with peptide ex vivo. In contrast, all other CMV specificities (tetramer-positive) displayed minimal or only partial CD8 dependence. This suggests that YVL-specific responses depict a low-affinity TCR-MHC-peptide interaction, that is compensated by substantial CD8 involvement for functional purposes, yet cannot engage multivalent soluble ligands for ex vivo analysis. It is interesting that such a phenomenon is apparent in the face of a persistent virus infection such as CMV, where the responding cells represent an immunodominant response in that individual and may present a highly differentiated effector phenotype.
© 2010 The Authors. Immunology © 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722762      PMCID: PMC2999804          DOI: 10.1111/j.1365-2567.2010.03326.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  48 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

Authors:  J L Chen; P R Dunbar; U Gileadi; E Jäger; S Gnjatic; Y Nagata; E Stockert; D L Panicali; Y T Chen; A Knuth; L J Old; V Cerundolo
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

4.  Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia.

Authors:  J J Molldrem; P P Lee; C Wang; K Felio; H M Kantarjian; R E Champlin; M M Davis
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

5.  Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection.

Authors:  J D Wilson; G S Ogg; R L Allen; C Davis; S Shaunak; J Downie; W Dyer; C Workman; S Sullivan; A J McMichael; S L Rowland-Jones
Journal:  AIDS       Date:  2000-02-18       Impact factor: 4.177

6.  Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.

Authors:  C Retière; V Prod'homme; B M Imbert-Marcille; M Bonneville; H Vié; M M Hallet
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Detection of CD4+ autoreactive T cells in T1D using HLA class II tetramers.

Authors:  Helena Reijonen; William W Kwok; Gerald T Nepom
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

8.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

Authors:  M K Maini; C Boni; C K Lee; J R Larrubia; S Reignat; G S Ogg; A S King; J Herberg; R Gilson; A Alisa; R Williams; D Vergani; N V Naoumov; C Ferrari; A Bertoletti
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

9.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen.

Authors:  J V Spencer; T J Braciale
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  11 in total

Review 1.  Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Authors:  Michael L Freeman; Michael M Lederman; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

2.  CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.

Authors:  Michael L Freeman; Joseph C Mudd; Carey L Shive; Souheil-Antoine Younes; Soumya Panigrahi; Scott F Sieg; Sulggi A Lee; Peter W Hunt; Leonard H Calabrese; Sara Gianella; Benigno Rodriguez; Michael M Lederman
Journal:  Clin Infect Dis       Date:  2015-09-23       Impact factor: 9.079

3.  Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity.

Authors:  Stephanie K Dougan; Michael Dougan; Jun Kim; Jacob A Turner; Souichi Ogata; Hyun-Il Cho; Rudolf Jaenisch; Esteban Celis; Hidde L Ploegh
Journal:  Cancer Immunol Res       Date:  2013-08       Impact factor: 11.151

4.  TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.

Authors:  Mathilde Allard; Barbara Couturaud; Laura Carretero-Iglesia; Minh Ngoc Duong; Julien Schmidt; Gwennaëlle C Monnot; Pedro Romero; Daniel E Speiser; Michael Hebeisen; Nathalie Rufer
Journal:  JCI Insight       Date:  2017-07-20

5.  Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells.

Authors:  Sine Reker Hadrup; Dominik Maurer; Karoline Laske; Thomas Mørch Frøsig; Sofie Ramskov Andersen; Cedrik M Britten; Sjoerd H van der Burg; Steffen Walter; Cécile Gouttefangeas
Journal:  Cytometry A       Date:  2014-10-08       Impact factor: 4.355

6.  Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA.

Authors:  Stephen J Griffiths; Natalie E Riddell; Joanne Masters; Valentina Libri; Sian M Henson; Anne Wertheimer; Diana Wallace; Stuart Sims; Laura Rivino; Anis Larbi; David M Kemeny; Janko Nikolich-Zugich; Florian Kern; Paul Klenerman; Vince C Emery; Arne N Akbar
Journal:  J Immunol       Date:  2013-05-01       Impact factor: 5.422

7.  MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy.

Authors:  Georg Dössinger; Mario Bunse; Jeannette Bet; Julia Albrecht; Paulina J Paszkiewicz; Bianca Weißbrich; Isabell Schiedewitz; Lynette Henkel; Matthias Schiemann; Michael Neuenhahn; Wolfgang Uckert; Dirk H Busch
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

Review 8.  Functional avidity: a measure to predict the efficacy of effector T cells?

Authors:  Selena Viganò; Daniel T Utzschneider; Matthieu Perreau; Giuseppe Pantaleo; Dietmar Zehn; Alexandre Harari
Journal:  Clin Dev Immunol       Date:  2012-11-20

Review 9.  Lower Affinity T Cells are Critical Components and Active Participants of the Immune Response.

Authors:  Ryan J Martinez; Brian D Evavold
Journal:  Front Immunol       Date:  2015-09-10       Impact factor: 7.561

10.  Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations.

Authors:  Cristina Rius; Meriem Attaf; Katie Tungatt; Valentina Bianchi; Mateusz Legut; Amandine Bovay; Marco Donia; Per Thor Straten; Mark Peakman; Inge Marie Svane; Sascha Ott; Tom Connor; Barbara Szomolay; Garry Dolton; Andrew K Sewell
Journal:  J Immunol       Date:  2018-02-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.